Interestingly, plasma ADMA and FGF23 are inter-related each other in CKD patients [123,164], and a study based on two CKD cohorts described a competitive interaction between ADMA and FGF23 for the prediction of CKD progression. The gene discussed is FGF23; the disease is chronic kidney disease.